Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer-Reference-Cited by-同舟云学术

Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer

Published:2006-02 Issue:2 Volume:17 Page:322-329
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Nolè F.,Catania C.,Sanna G.,Imadalou K.,Munzone E.,Adamoli L.,Longerey B.,Blanchot G.,Goldhirsch A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/2/322/392295/mdj058.pdf

Reference40 articles.

1. Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumours;Marty;Ann Oncol,2001

2. Puozzo C. A simultaneous oral/intravenous population pharmacokinetics model for vinorelbine;Variol;Eur J Clin Pharmacol,2002

3. Lichinister et al. A phase II study of oral vinorelbine (NVBo) in first line locally advanced/metastatic breast cancer (ABC) chemotherapy;Freyer;J Clin Oncol,2003

4. Efficacy and safety of Navelbine oral (NVBo) in first line metastatic breast cancer (MBC);Amadori;Eur J Cancer,2001

5. Phase II trial of weekly intravenous vinorelbine in first line advanced breast cancer chemotherapy;Fumoleau;J Clin Oncol,1993

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inetetamab combined with pyrotinib and oral vinorelbine for patients with human epidermal growth factor receptor 2 positive advanced breast cancer: A single-arm phase 2 clinical trial;Cancer Pathogenesis and Therapy;2024-01

2. Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance;Clinical Breast Cancer;2022-10

3. Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis;Future Science OA;2021-12

4. Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer;Acta Oncologica;2020-12-01

5. The Real-World Ethics of Adaptive-Design Clinical Trials;Hastings Center Report;2017-11